Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVerici Dx Regulatory News (VRCI)

Share Price Information for Verici Dx (VRCI)

Share Price is delayed by 15 minutes
Get Live Data
0.375    0.00 (0.00%)
Bid:
0.35
Ask:
0.40
Spread: 0.05 (14.286%)
Market Cap: £8.30m
VRCI Live PriceLast checked at - London Stock Exchange

Intraday Verici Dx Share Chart

Net Asset Value(s)

26 Jan 2022 16:28

RNS Number : 7538Z
China Post Global
26 January 2022
 

 

FUND:

MARKET ACCESS NYSE ARCA GOLD BUGS INDEX UCITS ETF

DEALING DATE:

25/01/2022

NAV PER SHARE:

 

 

EUR 92.9912

GBP 77.6544

NUMBER OF SHARES IN ISSUE:

813,533

CODE:

GOLB

ISIN:

LU0259322260

 

 

FUND:

MARKET ACCESS ROGERS INTERNATIONAL COMMODITY INDEX UCITS ETF

DEALING DATE:

25/01/2022

NAV PER SHARE:

 

 

EUR 24.8409

GBP 20.7440

NUMBER OF SHARES IN ISSUE:

3,125,122

CODE:

RICI

ISIN:

LU0249326488

 

 

FUND:

MARKET ACCESS STOXX CHINA A MINIMUM VARIANCE INDEX UCITS ETF

DEALING DATE:

26/01/2022

NAV PER SHARE:

 

 

EUR 115.9559

GBP 96.8316

NUMBER OF SHARES IN ISSUE:

238,711

CODE:

M9SV

ISIN:

LU1750178011

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQQLFLLFLLBBD
Date   Source Headline
28th Jul 20255:19 pmRNSHolding(s) in Company
28th Jul 20254:55 pmRNSHolding(s) in Company
28th Jul 202510:23 amRNSHolding(s) in Company
25th Jul 20255:22 pmRNSHolding(s) in Company
25th Jul 20251:05 pmRNSHolding(s) in Company
25th Jul 20251:04 pmRNSHolding(s) in Company
24th Jul 20252:34 pmRNSHolding(s) in Company
22nd Jul 20257:00 amRNSWRAP Retail Offer for up to £500,000
21st Jul 20253:43 pmRNSResult of Placing & Subscription
21st Jul 20257:00 amRNSProposed Fundraising
30th Jun 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNSUpdate on funding to accelerate commercial growth
27th May 20252:42 pmRNSResult of General Meeting
9th May 20254:38 pmRNSPublication of Circular
6th May 202512:16 pmRNSHolding(s) in Company
10th Apr 20258:06 amRNSVerici Receives Medicare Coverage for Tutivia
7th Apr 20257:00 amRNSSignificant Test Growth with Medicare Pending
14th Jan 202511:01 amRNSHolding(s) in Company
11th Oct 20247:00 amRNSUpdate on Local Coverage Determination and Trading
31st Jul 20247:00 amRNSLaunch of PTRA Assay using Verici Dx's technology
15th Jul 20247:00 amRNSHalf-year Report
11th Jul 20242:00 pmRNSNotice of Results and Business Update
1st Jul 20247:00 amRNSSignificant milestone re Thermo Fisher agreement
25th Jun 20241:27 pmRNSResult of AGM
18th Jun 20247:00 amRNSTransfer of urine samples to Thermo Fisher
31st May 20241:57 pmRNSNotice of AGM and posting of Annual Report
31st May 202410:00 amRNSLaunch of patient-focused educational tool
30th May 20247:00 amRNS2023 Annual Results
24th May 20247:00 amRNSNew data to be presented at ATC
27th Feb 20244:08 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSHolding(s) in Company
21st Feb 20244:53 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSHolding(s) in Company
19th Feb 202412:35 pmRNSResult of General Meeting
14th Feb 20247:00 amRNSResult of Retail Offer
31st Jan 20247:00 amRNSVerici Dx announces new research initiative
26th Jan 202412:32 pmRNSPublication of Circular
25th Jan 202411:00 amRNSLaunch of Retail Offer
24th Jan 20246:11 pmRNSResult of Placing
24th Jan 202410:39 amRNSClose of Accelerated Bookbuild
24th Jan 20247:00 amRNSProposed Fundraising
8th Jan 20247:00 amRNSCAP accreditation
8th Jan 20247:00 amRNSMedicare National Payment Rate Confirmation
11th Dec 20237:00 amRNSTutiviaâ„¢ validation study published in Journal
29th Nov 20237:00 amRNSISO 27001 Information Security Certification
20th Nov 20237:00 amRNSInvestor Presentation
15th Nov 20237:00 amRNSCommercialisation agreement with Thermo Fisher
2nd Nov 20237:00 amRNSClaravaâ„¢ poster to be presented at ASN Kidney Week
29th Sep 20237:00 amRNSHalf-year Report
20th Jul 20237:00 amRNSCLIA Certificate of Compliance update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.